Literature DB >> 1930862

Reassessment of the predictive value of the postural stimulation test in primary aldosteronism.

R G Fontes1, C E Kater, E G Biglieri, I Irony.   

Abstract

Postural stimulation tests (PST) from 146 patients with primary aldosteronism were reviewed: 83 had an aldosterone-producing adenoma (APA), 48 idiopathic hyperaldosteronism (IHA), nine primary adrenal hyperplasia (PAH), and six aldosterone-producing renin-responsive adenoma (AP-RA). Plasma aldosterone and cortisol levels were measured after overnight recumbency and in response to upright posture for 2 to 4 h. The test was considered invalid in 32% of the patients because cortisol levels increased during the maneuver. As both cortisol and aldosterone are responsive to ACTH in subjects with primary aldosteronism, as well as in normal subjects, we examined their percent variation instead of the absolute values. In order to validate those tests in which cortisol increased, we subtracted the percent cortisol change from the percent aldosterone response. An aldosterone increase of less than 30% (considered a positive response for the presence of an adenoma) identified 76 of the 89 patients with an adenoma (APA and AP-RA) (sensitivity of 85%). Among the 13 false-negative tests, six were proven cases of AP-RA. In each and every case an adenoma was detected by CT/MRI scanning (or bilateral adrenal vein catheterization). Hypertension was ameliorated or cured by surgery. A postural response of less than 30% was also present in 11 of the 57 patients who did not have a discrete adenoma confirmed by imaging techniques (specificity of 81%). Among these false-positive results there were the nine cases of PAH where the hypertension could be ameliorated or cured by partial removal of hyperplastic adrenal tissue.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1930862     DOI: 10.1093/ajh/4.9.786

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

Review 1.  Secondary hypertension. An overview of its causes and management.

Authors:  D H Streeten; G H Anderson
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

2.  Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.

Authors:  Zeng Guo; Kazutaka Nanba; Aaron Udager; Brett C McWhinney; Jacobus P J Ungerer; Martin Wolley; Moe Thuzar; Richard D Gordon; William E Rainey; Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

Review 3.  Assessing the quality of guidelines for primary aldosteronism: which guidelines are worth applying in diverse settings?

Authors:  Jueli Wu; Wenqing Tian; Lu Zhang; Jiao Zhang; Bo Zhou
Journal:  J Hypertens       Date:  2019-07       Impact factor: 4.844

4.  Reassessment of Postural Stimulation Testing as a Simple Tool to Identify a Subgroup of Patients With Unilateral Primary Aldosteronism.

Authors:  Carmina Teresa Fuss; Katharina Brohm; Martin Fassnacht; Matthias Kroiss; Stefanie Hahner
Journal:  J Clin Endocrinol Metab       Date:  2022-01-18       Impact factor: 5.958

5.  Adrenal Venous Sampling Could Be Omitted before Surgery in Patients with Conn's Adenoma Confirmed by Computed Tomography and Higher Normal Aldosterone Concentration after Saline Infusion Test.

Authors:  Robert Holaj; Petr Waldauf; Dan Wichterle; Jan Kvasnička; Tomáš Zelinka; Ondřej Petrák; Zuzana Krátká; Lubomíra Forejtová; Jan Kaván; Jiří Widimský
Journal:  Diagnostics (Basel)       Date:  2022-07-15

6.  A clinical prediction score using age at diagnosis and saline infusion test parameters can predict aldosterone-producing adenoma from idiopathic adrenal hyperplasia.

Authors:  H T Leung; Y C Woo; C H Y Fong; K C B Tan; E Y F Lau; K W Chan; J Y Y Leung
Journal:  J Endocrinol Invest       Date:  2019-09-16       Impact factor: 4.256

Review 7.  Recent Development toward the Next Clinical Practice of Primary Aldosteronism: A Literature Review.

Authors:  Yuta Tezuka; Yuto Yamazaki; Yasuhiro Nakamura; Hironobu Sasano; Fumitoshi Satoh
Journal:  Biomedicines       Date:  2021-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.